The rising prevalence in GLP-1 drugs for diabetes has generated a debate about delivery methods : skin-applied devices versus tablets . Usually , GLP-1 therapies were exclusively available in tablet https://minahulp728258.liberty-blog.com/41236734/glp-1-skin-applications-vs-tablets-what-best-for-the-patient